[1]任文君,王泽阳,黄 欣,等.肝动脉化疗栓塞术联合125I放射性粒子植入术与单独肝动脉化疗栓塞术治疗肝癌的meta分析[J].介入放射学杂志,2019,28(02):132-137.
 REN Wenjun,WANG Zeyang,HUANG Xin,et al.TACE combined with 125I seed implantation vs simple TACE for the treatment of liver cancer: a meta analysis[J].journal interventional radiology,2019,28(02):132-137.
点击复制

肝动脉化疗栓塞术联合125I放射性粒子植入术与单独肝动脉化疗栓塞术治疗肝癌的meta分析()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
28
期数:
2019年02期
页码:
132-137
栏目:
肿瘤介入
出版日期:
2019-02-25

文章信息/Info

Title:
TACE combined with 125I seed implantation vs simple TACE for the treatment of liver cancer: a meta analysis
作者:
任文君 王泽阳 黄 欣 曹国辉 隋爱霞 赵 静 张宏涛
Author(s):
REN Wenjun WANG Zeyang HUANG Xin CAO Guohui SUI Aixia ZHAO Jing ZHANG Hongtao.
 Department of Oncology, Hebei Provincial People’s Hospital, Shijiazhuang, Hebei Province 050051, China
关键词:
【关键词】 肝癌 肝动脉化疗栓塞术 125I粒子植入术 荟萃分析
文献标志码:
A
摘要:
【摘要】 目的 对比肝动脉化疗栓塞术(TACE)联合125I粒子植入术与单独TACE治疗肝癌的临床疗效。方法 计算机检索关于TACE联合125I粒子植入术与单独TACE治疗肝癌的随机对照试验(RCT)研究,纳入分析近期、远期疗效及并发症。结果 纳入7篇RCT,498例患者,meta分析结果:联合组的完全缓解(CR)、部分缓解(PR)、稳定(SD)、1、2、3年生存率明显高于单纯治疗组,而进展(PD)明显低于单纯治疗(对照)组,P<0.05差异均有统计学意义,并发症方面两组均未出现放射性邻近器官坏死及全身严重不良反应,对症治疗可缓解。结论 TACE联合125I放射性粒子植入术治疗肝癌疗效优于单独TACE治疗。

参考文献/References:

[1] 张 辉, 莫日根. TACE联合CT导向下125I放射性粒子植入治疗肝癌[J]. 介入放射学杂志, 2009, 18: 702- 704.
[2] 姚红响, 陈根生, 诸葛英, 等. 肝动脉化疗栓塞联合CT引导射频消融序贯治疗中小肝癌的临床应用[J]. 介入放射学杂志, 2012, 21: 301- 304.
[3] 欧盛秋, 韦长元, 马亦龙, 等. 125I放射性粒子联合TACE治疗原发性肝癌的临床观察[J]. 中华肿瘤防治杂志, 2014, 21: 1373- 1375.
[4] 李 庆, 曹苏娟, 龙文兴, 等. 125I粒子植入术联合TACE治疗大肝癌的临床效果[J]. 中国医药导报, 2016, 13: 73- 77.
[5] 严 丽, 曾兆云, 熊宗恒, 等. 125I粒子植入联合肝动脉化疗栓塞治疗晚期肝癌的临床疗效[J]. 医学临床研究, 2016, 33: 2449- 2451.
[6] 曹贵文, 杜苗苗, 崔新江, 等. TACE联合125I放射性粒子植入序贯治疗近心旁原发性肝细胞肝癌效果观察[J]. 山东医药, 2017, 57: 55- 57.
[7] 金光鑫, 王 智, 王 军, 等. 肝动脉化疗栓塞联合125I粒子植入治疗原发性肝癌的临床研究[J]. 实用癌症杂志, 2016, 31: 1957- 1959.
[8] 李 靖, 肖金成, 郑 琳, 等. 含洛铂方案经肝动脉化疗栓塞联合125I粒子植入术治疗不能手术的中晚期肝癌的疗效观察[J]. 中国癌症杂志, 2017, 27: 896- 902.
[9] 王朝栋, 党国际, 陈锦州, 等. 经皮肝动脉碘油化疗栓塞联合CT引导下125I放射性粒子植入治疗巨块型肝癌[J]. 中国伤残医学, 2015, 23: 12- 14.
[10] 肖利军. 初治原发性肝癌TACE前后VEGF的变化分析及对疗效的评估[D]. 广州: 南方医科大学, 2016: 1- 51.
[11] 梁 宇, 段留新, 郝法涛, 等. 血清VEGF对肝癌TACE治疗疗效的判断价值[J]. 肿瘤药学, 2017, 7: 355- 359.
[12] 冉 琳, 任伯绪. 125I粒子组织间近距离放射治疗肝癌的现状与进展[J]. 介入放射学杂志, 2012, 21: 876- 878.
[13] 沈颖甜, 朱海东, 陈 荔, 等. 肝内胆管细胞癌诊疗研究进展[J]. 介入放射学杂志, 2018, 27: 285- 289.
[14] 黄 宁, 杨维竹, 江 娜, 等. 经导管动脉化疗栓塞术联合经皮125I粒子植入序贯治疗肝癌伴门静脉主干癌栓[J]. 中华介入放射学电子杂志, 2014, 2: 11- 15.

相似文献/References:

[1]叶更新,曾文,杜德坤,等.肝动脉栓塞与经皮碘油标记酒精注射联合治疗晚期肝癌[J].介入放射学杂志,1996,(01):42.
[2]杨永波,程红岩.肝动脉化疗栓塞治疗中碘油用量的现状与研究进展[J].介入放射学杂志,2012,(04):348.
 .The volume of Lipiodol used in TACE: its current situation and research progress [J].journal interventional radiology,2012,(02):348.
[3]施长杲,吕维富,鲁 东,等.肝动脉化疗栓塞术后并发肝脓肿5例治疗分析[J].介入放射学杂志,2011,(04):273.
 SHI Chang-gao,LV Wei-fu,LU Dong,et al.The treatment of liver abscess occurred after transcatheter arterial chemoembolization report of five cases[J].journal interventional radiology,2011,(02):273.
[4]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗30例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
 ,,et al.TACE combined with radiofrequency ablation for massive primary hepatocellular carcinomas: a clinical therapeutic evaluation [J].journal interventional radiology,2012,(02):322.
[5]张   磊,陆骊工,李   勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,(12):968.
 ZHANG Lei,LU Li-gong,LI Yong,et al.Portal vein stent placement combined with TACE for the treatment of hepatocellular carcinoma associated with tumor thrombus in portal vein[J].journal interventional radiology,2011,(02):968.
[6]敖 劲,张跃伟,徐 克. 明胶海绵微粒经动脉栓塞治疗原发性肝癌的研究现状[J].介入放射学杂志,2011,(12):1010.
 AO Jin,ZHANG Yue-wei,XU Ke..Gelatin sponge particle used as an embolic agent in transcatheter arterial chemoembolization treatment for primary hepatocellular carcinoma: its current situation in research[J].journal interventional radiology,2011,(02):1010.
[7]杜丹丹,吕维富. 肝癌射频消融后的影像学评价[J].介入放射学杂志,2012,(01):75.
 DU Dan dan,Lv Wei fu..Imaging evaluation of liver cancer after radiofrequency ablation therapy[J].journal interventional radiology,2012,(02):75.
[8]赵 艳,韩国宏,白 苇,等. 药物缓释微球肝动脉化疗栓塞治疗肝癌研究进展[J].介入放射学杂志,2012,(01):78.
 ZHAO Yan,HAN Guo-hong,BAI Wei,et al.Transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma: its research progress[J].journal interventional radiology,2012,(02):78.
[9]何海涛,刘 圣,刘建秦,等. 肝癌TACE术并发脑碘油栓塞二例并文献复习[J].介入放射学杂志,2012,(08):682.
 HE Hai- tao,LIU sheng,LIU Jian- qing,et al. Cerebral Lipiodol embolism occurred after transcatheter arterial chemoembolization for hepatocellular carcinoma: report of two cases with literature review[J].journal interventional radiology,2012,(02):682.
[10]刘纪营,马 南,管 生,等. 预防性应用抗生素的不同方法对介入治疗并发肝脓肿的影响[J].介入放射学杂志,2013,(06):474.
 LIU Ji? ying,MA Nan,GUAN Sheng,et al. The influence of different using methods of antibiotic prophylaxis on the occurrence of liver abscess after transcatheter hepatic arterial chemoembolization[J].journal interventional radiology,2013,(02):474.
[11]纪建红,郑群丽,陈思倩,等.TACE联合射频消融术治疗巨块型肝癌的护理[J].介入放射学杂志,2013,(12):1052.
 JI Jian? hong,ZHENG Qun? li,CHEN Si? qian,et al.Nursing care for patients with massive hepatocellular carcinoma receiving combination therapy of TACE and radiofrequency ablation[J].journal interventional radiology,2013,(02):1052.
[12]臧 爽,徐 阳,梁松年.原发性肝癌患者经肝动脉化疗栓塞术后住院天数影响因素的多元线性回归分析[J].介入放射学杂志,2015,(01):80.
 ZANG Shuang,XU Yang,LIANG Song nian..Multiple linear regression analysis of factors related to the hospitalization days in HCC patients after transcatheter hepatic arterial chemoembolization[J].journal interventional radiology,2015,(02):80.
[13]赵凯凯,司友娇,黄九宁,等.肝癌患者TACE术后对比剂肾病的危险因素[J].介入放射学杂志,2019,28(10):942.
 ZHAO Kaikai,SI Youjiao,HUANG Jiuning,et al.The risk factors for contrast- induced nephropathy in patients with HCC after TACE[J].journal interventional radiology,2019,28(02):942.
[14]江海林,孟小茜,廖华强,等.不同体位经桡动脉途径行TACE术的透视时间对比[J].介入放射学杂志,2021,30(03):275.
 JIANG Hailin,MENG Xiaoxi,LIAO Huaqiang,et al.Comparison of fluoroscopic time between different body positions in performing TACE via radial approach[J].journal interventional radiology,2021,30(02):275.
[15]李虎子,段振东,赵 成,等.TACE联合冷冻消融治疗不可切除肝癌临床疗效的meta分析[J].介入放射学杂志,2021,30(08):804.
 LI Huzi,DUAN Zhendong,ZHAO Cheng,et al.TACE combined with cryoablation for inoperable liver cancers: a meta analysis of clinical efficacy[J].journal interventional radiology,2021,30(02):804.
[16]刘秀芳,张伟伟,吴海平,等.多学科协作干预模式在TACE治疗原发性肝癌患者中的应用效果 [J].介入放射学杂志,2021,30(10):1057.
 LIU Xiufang,ZHANG Weiwei,WU Haiping,et al.The application value of multi-disciplinary team intervention mode in HCC patients receiving TACE[J].journal interventional radiology,2021,30(02):1057.
[17]王怡博,冯广森.左侧桡动脉和右侧桡动脉入路TACE治疗的对比分析[J].介入放射学杂志,2023,32(12):1226.
 WANG Yibo,FENG Guangsen..Left transradial approach versus right transradial approach for TACE treatment: a comparative study[J].journal interventional radiology,2023,32(02):1226.
[18]梁 轶,严忠婷,桑玉还,等.肝癌患者肝动脉化疗栓塞术后恶心和呕吐的危险因素及评估工具研究进展[J].介入放射学杂志,2024,33(05):565.
 LIANG Yi,YAN Zhongting,SANG Yuhuan,et al.Research progress in risk factors and evaluation tools for nausea and vomiting after hepatic artery chemoembolization in liver cancer patients[J].journal interventional radiology,2024,33(02):565.

备注/Memo

备注/Memo:
(收稿日期:2018-03-24)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2019-02-20